Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome.

Ashley Ringrose, Youwen Zhou, Emily M. Pang, +5

Blood

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease

Wolfgang Eisterer, Xiaoyan Jiang, Oliver Christ, +11

Leukemia

Cell TherapyMedicineStem Cell MobilizationStem Cell TransplantationImmunology +10

Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate

Xiaoyan Jiang, Donna L. Forrest, Franck E. Nicolini, +16

Blood

Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia

Xiaoyan Jiang, Yun Zhao, Wing-Yiu Chan, +6

Blood

Increased Stiffness Inhibits Invadopodia Formation and Cell Migration in 3D

Julie Chang, Emily M. Pang, Kolade Adebowale, +2

Biophysical Journal

MechanobiologyDevelopmental BiologyEngineeringBiomechanicsBiofabrication +10

Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas

Ashley Ringrose, Youwen Zhou, Emily M. Pang, +8

Leukemia

Hematological MalignancyOncogenic RoleLymphoid NeoplasiaOncogenic AgentHematology +9

Advancing Health Equity by Translating Lessons Learned from NICU Family Visitations During the COVID-19 Pandemic

Emily M. Pang, Rachelle Sey, Theodore De Beritto, +2

NeoReviews

Family MedicineHealthcare ProvisionSocial Determinants Of HealthNicu Family VisitationsNicu Visitation +24

Leukemic Stem Cells of Chronic Phase CML Patients Consistently Display Very High BCR-ABL Transcript Levels and Reduced Responsiveness to Imatinib Mesylate in Addition to Generating a Rare Subset That Produce Imatinib Mesylate-Resistant Differentiated Progeny.

Xiaoyan Jiang, Yun Zhao, Wing Yiu Chan, +3

Blood

Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing

Han Kiat Ho, G. Nemeth, Yakunina Ng, +14

Current Medicinal Chemistry

Evaluating Care in Safety Net Hospitals: Clinical Outcomes and Neonatal Intensive Care Unit Quality of Care in California

Jessica Liu, Emily M. Pang, Alexandra Iacob, +3

The Journal of Pediatrics